Covenant Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Hold
0
-$9.2M 173
2026
Q1
Hold
0
20
2025
Q4
Hold
0
28
2025
Q1
Hold
0
-$3.86M 165
2024
Q4
Hold
0
51
2024
Q3
Hold
0
45
2024
Q1
Hold
0
-$6.7M 154
2023
Q4
Hold
0
16
2023
Q1
Hold
0
-$1.46M 175
2022
Q4
Hold
0
84
2022
Q3
Hold
0
4

Other funds holding LLY

Covenant Asset Management's LLY Position: Q2 2026 in Review

Covenant Asset Management reduced its Eli Lilly (LLY) stake by 0.08% in Q2 2026, selling an estimated $7.15K and leaving 8,957 shares worth $10.7M. The position accounts for 1.81% of the portfolio, ranked #13.

Covenant Asset Management first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. The position peaked at $10.8M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Covenant Asset Management held 8,957 shares of Eli Lilly worth $10.7M as of Q2 2026.
  • Covenant Asset Management sold 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 1.81% of Covenant Asset Management's portfolio in Q2 2026, its #13 holding.
  • Covenant Asset Management first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • Covenant Asset Management's Eli Lilly position peaked at $10.8M in Q2 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Covenant Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.